טוען...
Targeting prostate cancer with radiolabelled bombesins
The fact that a number of common human tumours, including those of breast and prostate, express increased levels of the gastrin-releasing peptide receptor (GRP-R) means that this receptor is a potential target for peptide receptor mediated scintigraphy and targeted radionuclide therapy. Although cli...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | English |
| יצא לאור: |
e-MED
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1693771/ https://ncbi.nlm.nih.gov/pubmed/17098646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1102/1470-7330.2006.0025 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|